篮球赔率

篮球赔率 Services FAQ Contact Us 0
Home Biotechnology Europe Genetic Testing Market Analysis,聽Trends,聽Forecast聽Up to 2030
Europe Genetic Testing Market
Select Regional / Country Report
Global Asia Pacific Europe North America LAMEA

Europe Genetic Testing Market Size, Share & Trends Analysis Report By Product Type (Instrument, Consumables and Accessories, Software and Service), By Type (Diagnostic Imaging Tests, Biopsy and Cytology Tests, Tumor Biomarkers, Other Diagnostic Types), By Technology (Instrument Based,, Platform-Based, Tumor Biomarker Tests), By Distribution Channel (Direct tenders, Retail Sales), By Application (Breast Cancer, Lung Cancer, Cervical Cancer, Kidney Cancer, Liver Cancer, Pancreatic Cancer, Ovarian Cancer, Other Applications), By End-User (Hospital, Oncology Speciality Clinics, Diagnostic Laboratories, Cancer Research Institutes, Others) and By Country(U.K., Germany, France, Spain, Italy, Russia, Nordic, Benelux, Rest of Europ) Forecasts, 2022-2030

Report Code: SRBI3224DR
Author : 篮球赔率
Buy Now
File Formats

Table Of Content

  1. Executive Summary
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
    1. Europe
  2. ESG Trends
    1. Introduction
    2. By Type
      1. Introduction
        1. Type By Value
      2. Predictive Testing & Presymptomatic Testing
        1. By Value
      3. Carrier Testing
        1. By Value
      4. Prenatal & Newborn Testing
        1. By Value
      5. Diagnostic Testing
        1. By Value
      6. Pharmacogenomic Testing
        1. By Value
      7. Others
        1. By Value
    3. By Technique
      1. Introduction
        1. Technique By Value
      2. Polymerase chain reaction (PCR)
        1. By Value
      3. DNA Sequencing
        1. By Value
      4. Cytogenetics
        1. By Value
      5. Microarrays
        1. By Value
      6. Others
        1. By Value
    4. By Application
      1. Introduction
        1. Application By Value
      2. Oncology
        1. By Value
      3. Cardiovascular Disease Diagnosis
        1. By Value
      4. Neurological Disorders
        1. By Value
      5. Genetic Disorders
        1. By Value
      6. Others
        1. By Value
    5. By End User
      1. Introduction
        1. End User By Value
      2. Hospitals & Clinics
        1. By Value
      3. Diagnostic Laboratories
        1. By Value
      4. Others
        1. By Value
    6. U.K.
      1. By Type
        1. Introduction
          1. Type By Value
        2. Predictive Testing & Presymptomatic Testing
          1. By Value
        3. Carrier Testing
          1. By Value
        4. Prenatal & Newborn Testing
          1. By Value
        5. Diagnostic Testing
          1. By Value
        6. Pharmacogenomic Testing
          1. By Value
        7. Others
          1. By Value
      2. By Technique
        1. Introduction
          1. Technique By Value
        2. Polymerase chain reaction (PCR)
          1. By Value
        3. DNA Sequencing
          1. By Value
        4. Cytogenetics
          1. By Value
        5. Microarrays
          1. By Value
        6. Others
          1. By Value
      3. By Application
        1. Introduction
          1. Application By Value
        2. Oncology
          1. By Value
        3. Cardiovascular Disease Diagnosis
          1. By Value
        4. Neurological Disorders
          1. By Value
        5. Genetic Disorders
          1. By Value
        6. Others
          1. By Value
      4. By End User
        1. Introduction
          1. End User By Value
        2. Hospitals & Clinics
          1. By Value
        3. Diagnostic Laboratories
          1. By Value
        4. Others
          1. By Value
    7. Germany
    8. France
    9. Spain
    10. Italy
    11. Russia
    12. Nordic
    13. Benelux
    14. Rest of Europ
    1. Europe Genetic Testing Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    1. hoffmann-la roche ltdI
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. QIAGEN
    3. DiaSorin S.P.A.
    4. Siemens Healthcare GmbH
    5. bioMérieux
    6. Biocartis
    1. Research Data
      1. Secondary Data
        1. Major secondary sources
        2. Key data from secondary sources
      2. Primary Data
        1. Key data from primary sources
        2. Breakdown of primaries
      3. Secondary And Primary Research
        1. Key industry insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  3. Disclaimer

Related Reports

Global Report
Cancer Genetic Testing Market Size The global cancer genetic testing market size was valued at USD 6.70 billion in 2024 and is projected to reach from USD 7.47 billion in 2025 to USD 17.98 billion by 2033, growing at a CAGR of 11.6% during the forec
Buy Now
Global Report
EMC Testing Market Size The global EMC testing market size was valued at USD 2.62 billion in 2024 and is projected to grow from USD 2.75 billion in 2025 to USD 4.03 billion by 2033, exhibiting a CAGR of 4.9% during the forec
Buy Now
Global Report
Esoteric Testing Market Size The global esoteric testing market size was valued at USD 28.8 billion in 2024 and is projected to reach from USD 32.03 billion in 2025 to USD 74.78 billion by 2033, growing at a CAGR of 11.2% during the forecast period
Buy Now
Global Report
Market Overview The global generative design market size is projected to reach USD 7 billion by 2030, from USD 2 billion in 2021, and is anticipated to register a CAGR of 16 % during 2022–2030. A design exploration approach is known as genera
Buy Now
Global Report
Metabolic Testing Market Size The global metabolic testing market size was valued at USD 547.32 million in 2024 and is projected to grow from USD 589.03 million in 2025 to USD 1,060.82 million by 2033, growing at a CAGR of 7.63% during the fore
Buy Now

Purchase Benefits

  • Eligible for a free updated report next year
  • Completely customizable scope
  • 30% discount on your next purchase
  • Dedicated account manager
  • Query resolution within 24 hours
  • Permission to print the report

We are featured on :

篮球赔率
漏 Copyright . All rights Reserved.